Clinical Trial Update: Investigate Role of Metabolic Imaging in Predicting Tumor Response/Outcome After Pancreatic CA Tx [NA]

View source ↗

Summary

A completed Stanford-led clinical trial evaluated metabolic imaging for predicting tumor response and outcomes after pancreatic cancer treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Stanford University | Conditions: Pancreatic Cancer | NA | Status: COMPLETED